Legislation affecting the production of medical isotopes
Proposed legislation to reauthorize the DOE Isotope Program
Appropriations for DOE isotope production
NRC rules impacting the use of radiopharmaceuticals
Proposed trade restrictions on the supply of industrial and medical isotopes
Duration: January 1, 2017
to
present
General Issues: Energy/Nuclear , Trade (Domestic & Foreign) , Transportation , Chemicals/Chemical Industry
Spending: about $810,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2017: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Allison Trexler Policy Director, House Energy and Commerce and Chairman Ed Whitfield
Tara Billingsley Special Assistant to the President and Senate Legislative Affairs Liaison
Special Assistant to the President and senate Legislative Affairs Liaison
Troy Lyons Associate Administrator, Office of Congressional & Intergovernmental Relations, and Senior Advisor to the Administrator for External Affairs
Elliot Howard Professional Staff Member, Senate Energy and Natural Resources Committee and Chairman Joe Manchin
Alexander Dominguez Professional Staff Member, Congressman Jim Renacci
Professional Staff Member, Congressman James Renacci
James Massie n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on April 19.
Original Filing: 301566164.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to reauthorize the DOE Isotope Program
Appropriations for DOE isotope production
NRC rules impacting the use of radiopharmaceuticals
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed trade restrictions on the supply of industrial and medical isotopes
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2023
In Q4, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on Jan. 22.
Original Filing: 301540271.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to reauthorize the DOE Isotope Program
Appropriations for DOE isotope production
NRC rules impacting the use of radiopharmaceuticals
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed trade restrictions on the supply of industrial and medical isotopes
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2023
In Q3, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on Oct. 20, 2023.
Original Filing: 301513671.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to reauthorize the DOE Isotope Program
Appropriations for DOE isotope production
NRC rules impacting the use of radiopharmaceuticals
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed trade restrictions on the supply of industrial and medical isotopes
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2023
In Q2, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on July 20, 2023.
Original Filing: 301487728.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to reauthorize the DOE Isotope Program
Appropriations for DOE isotope production
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed trade restrictions on the supply of industrial and medical isotopes
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2023
In Q1, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on April 20, 2023.
Original Filing: 301465035.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
proposed legislation to reauthorize the DOE Isotope program
Appropriations for DOE isotope production
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed trade restrictions on the supply of industrial and medical isotopes
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2022
In Q4, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on Jan. 20, 2023.
Original Filing: 301438694.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to reauthorize the DOE Isotope Program
Energy and Water Development and Related Agencies Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed trade restrictions on the supply of industrial and medical isotopes
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2022
In Q3, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on Oct. 20, 2022.
Original Filing: 301413787.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to reauthorize the DOE Isotope Program
Energy and Water Development and Related Agencies Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed trade restrictions on the supply of industrial and medical isotopes
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising rules governing packaging and distribution of radioactive materials
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on July 20, 2022.
Original Filing: 301390738.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to reauthorize the DOE Isotope Proram
Energy and Water Development and Related Agencies Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed trade restrictions on the supply of industrial and medical isotopes
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising rules governing packaging and distribution of radioactive materials
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on April 20, 2022.
Original Filing: 301366910.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilities
Energy and Water Development and Related Agencies Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on Jan. 20, 2022.
Original Filing: 301337517.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilities
Energy and Water Development and Related Agencies Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on Oct. 20, 2021.
Original Filing: 301313384.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilities
Energy and Water Development and Related Agencies Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on July 20, 2021.
Original Filing: 301285880.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilities
Energy and Water Development and Related Agencies Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $20,000. The report was filed on April 20, 2021.
Original Filing: 301266305.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilities
Energy and Water Development and Related Agencies Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on Jan. 20, 2021.
Original Filing: 301238324.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R.1760 - Advanced Nuclear Fuel Availability Act
H.R.2960 - Energy and Water Development and Related Agencies Appropriations Act, 2020
S.903 - Nuclear Energy Leadership Act
S.2470 - Energy and Water Development and Related Agencies Appropriations Act, 2020
H.R. 133 - Consolidated Appropriations Act, 2021
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed Uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of CFATS
H.R.3256 - Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2019
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
3rd Quarter, 2020
In Q3, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on Oct. 19, 2020.
Original Filing: 301216270.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R.1760 - Advanced Nuclear Fuel Availability Act
H.R.2960 - Energy and Water Development and Related Agencies Appropriations Act, 2020
S.903 - Nuclear Energy Leadership Act
S.2470 - Energy and Water Development and Related Agencies Appropriations Act, 2020
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed Uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of CFATS
H.R.3256 - Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2019
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
2nd Quarter, 2020
In Q2, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on July 17, 2020.
Original Filing: 301191264.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R.1760 - Advanced Nuclear Fuel Availability Act
H.R.2960 - Energy and Water Development and Related Agencies Appropriations Act, 2020
S.903 - Nuclear Energy Leadership Act
S.2470 - Energy and Water Development and Related Agencies Appropriations Act, 2020
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed Uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of CFATS
H.R.3256 - Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2019
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
1st Quarter, 2020
In Q1, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on April 16, 2020.
Original Filing: 301167988.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R.1760 - Advanced Nuclear Fuel Availability Act
H.R.2960 - Energy and Water Development and Related Agencies Appropriations Act, 2020
S.903 - Nuclear Energy Leadership Act
S.2470 - Energy and Water Development and Related Agencies Appropriations Act, 2020
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed Uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of CFATS
H.R.3256 - Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2019
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
4th Quarter, 2019
In Q4, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on Jan. 15, 2020.
Original Filing: 301105930.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R.1760 - Advanced Nuclear Fuel Availability Act
H.R.2960 - Energy and Water Development and Related Agencies Appropriations Act, 2020
S.903 - Nuclear Energy Leadership Act
S.2470 - Energy and Water Development and Related Agencies Appropriations Act, 2020
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed Uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of CFATS
H.R.3256 - Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2019
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
3rd Quarter, 2019
In Q3, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on Oct. 18, 2019.
Original Filing: 301069831.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R.1760 - Advanced Nuclear Fuel Availability Act
H.R.2960 - Energy and Water Development and Related Agencies Appropriations Act, 2020
S.903 - Nuclear Energy Leadership Act
S.2470 - Energy and Water Development and Related Agencies Appropriations Act, 2020
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed Uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
Lobbying Issues
Reauthorization of CFATS
H.R.3256 - Protecting and Securing Chemical Facilities from Terrorist Attacks Act of 2019
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
2nd Quarter, 2019
In Q2, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on July 16, 2019.
Original Filing: 301046267.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R.2960 - Energy and Water Development and Related Agencies Appropriations Act, 2020
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed Uranium trade restrictions and 232 investigations
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
Lobbying Issues
Legislation revising NRC rules governing packaging and distribution of radiation materials
Agencies Lobbied
U.S. Senate
Agencies Lobbied
U.S. Senate
Type of Issue
Chemicals/Chemical Industry
1st Quarter, 2019
In Q1, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on April 18, 2019.
Original Filing: 301028166.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R.1589 - CBRN Intelligence and Information Sharing Act of 2019
Agencies Lobbied
U.S. Senate
Lobbying Issues
Proposed Uranium trade restrictions and 232 investigations
Legislation revising NRC rules governing packaging and distribution of radiation materials
Reauthorization of CFATS
Agencies Lobbied
U.S. Senate
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2018
In Q4, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on Jan. 18, 2019.
Original Filing: 301008834.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R. 244 - Consolidated Appropriation Act, 2017
H.R. 590 - Advanced Nuclear Technology Development Act of 2017
H.R. 1320 - Nuclear Utilization of Keynote Energy Act
H.R. 3053 - Nuclear Waste Policy Amendments Act of 2017
H.R. 3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
H.R. 5515 - National Defense Authorization Act for Fiscal Year 2018
S. 512 - Nuclear Energy Innovation and Modernization Act
S. 1519 - National Defense Authorization Act for Fiscal Year 2018
S. 1609 - Energy and Water Development and Related Agencies Appropriations Act, 2018
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $30,000. The report was filed on Oct. 19, 2018.
Original Filing: 300990473.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R. 244 - Consolidated Appropriation Act, 2017
H.R. 590 - Advanced Nuclear Technology Development Act of 2017
H.R. 1320 - Nuclear Utilization of Keynote Energy Act
H.R. 3053 - Nuclear Waste Policy Amendments Act of 2017
H.R. 3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
H.R. 5515 - National Defense Authorization Act for Fiscal Year 2018
S. 512 - Nuclear Energy Innovation and Modernization Act
S. 1519 - National Defense Authorization Act for Fiscal Year 2018
S. 1609 - Energy and Water Development and Related Agencies Appropriations Act, 2018
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $40,000. The report was filed on July 19, 2018.
Original Filing: 300971609.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R. 3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
S. 1609 - Energy and Water Development and Related Agencies Appropriations Act, 2018
H.R. 590 -- Advanced Nuclear Technology Development Act of 2017
H.R. 1320 - Nuclear Utilization of Keynote Energy Act
S. 512 - Nuclear Energy Innovation and Modernization Act
H.R. 3053 - Nuclear Waste Policy Amendments Act of 2017
H.R. 5515 - National Defense Authorization Act for Fiscal Year 2018
S. 1519 - National Defense Authorization Act for Fiscal Year 2018
H.R. 244 - Consolidated Appropriation Act, 2017
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $40,000. The report was filed on April 20, 2018.
Original Filing: 300953830.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R. 3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
S. 1609 - Energy and Water Development and Related Agencies Appropriations Act, 2018
H.R. 590 -- Advanced Nuclear Technology Development Act of 2017
H.R. 1320 - Nuclear Utilization of Keynote Energy Act
S. 512 - Nuclear Energy Innovation and Modernization Act
H.R. 3053 - Nuclear Waste Policy Amendments Act of 2017
H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018
S. 1519 - National Defense Authorization Act for Fiscal Year 2018
H.R. 1625 - Consolidated Appropriations Act, 2018
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $40,000. The report was filed on Jan. 22, 2018.
Original Filing: 300932995.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R. 3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
S. 1609 - Energy and Water Development and Related Agencies Appropriations Act, 2018
H.R. 590 -- Advanced Nuclear Technology Development Act of 2017
H.R. 1320 - Nuclear Utilization of Keynote Energy Act
S. 512 - Nuclear Energy Innovation and Modernization Act
H.R. 3053 - Nuclear Waste Policy Amendments Act of 2017
H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018
S. 1519 - National Defense Authorization Act for Fiscal Year 2018
H.R. 244 - Consolidated Appropriation Act, 2017
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $40,000. The report was filed on Oct. 19, 2017.
Original Filing: 300910422.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
H.R. 3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
S. 1609 - Energy and Water Development and Related Agencies Appropriations Act, 2018
H.R. 590 -- Advanced Nuclear Technology Development Act of 2017
H.R. 1320 - Nuclear Utilization of Keynote Energy Act
S. 512 - Nuclear Energy Innovation and Modernization Act
H.R. 3053 - Nuclear Waste Policy Amendments Act of 2017
H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018
S. 1519 - National Defense Authorization Act for Fiscal Year 2018
H.R. 244 - Consolidated Appropriation Act, 2017
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $40,000. The report was filed on July 19, 2017.
Original Filing: 300890184.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
House Energy & Water Appropriations
Senate Energy & Water Appropriations
H.R. 590, Advanced Nuclear Technology Development Act of 2017
H.R. 1320, Nuclear Utilization of Keynote Energy Act
S. 512, Nuclear Energy Innovation and Modernization Act
H.R. 3053, Nuclear Waste Policy Amendments Act of 2017
H.R. 2810 - National Defense Authorization Act for Fiscal Year 2018
H.R. 244 - Consolidated Appropriation Act, 2017
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Jim Massie & Partners, LLC lobbied for Council on Radionuclides and Radiopharmaceuticals , earning $40,000. The report was filed on April 19, 2017.
Original Filing: 300870022.xml
Lobbying Issues
Legislation affecting the production of medical isotopes
Proposed legislation to provide loan guarantees for medical isotope facilitates
House Energy & Water Appropriations
Senate Energy & Water Appropriations
H.R. 590, Advanced Nuclear Technology Development Act of 2017
H.R. 1320, Nuclear Utilization of Keynote Energy Act
S. 512, Nuclear Energy Innovation and Modernization Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
Jim Massie & Partners, LLC filed a lobbying registration on Jan. 23, 2017 to represent Council on Radionuclides and Radiopharmaceuticals, effective Jan. 1, 2017.
Original Filing: 300855778.xml
Issue(s) they said they’d lobby about: Legislation affecting the production of medical isotopes; Proposed legislation to provide loan guarantees for medical isotopes facilities; House Energy & Water Appropriations; Senate Energy & Water Appropriations .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...